JAMA Current Issue

Removing Ineffective Drugs From the Market

This Viewpoint examines the removal of ineffective licensed products from the market, specifically discussing the example of oral phenylephrine.

Mar 18, 2025 - 16:51
 0
This Viewpoint examines the removal of ineffective licensed products from the market, specifically discussing the example of oral phenylephrine.
Read More

Tags:

Previous Article

Home Temperature May Affect Cognitive Function in Older Adults

Next Article

Studies Find Low Risk of Thyroid Cancer With GLP-1 Drugs for Diabetes

Related Posts

Addressing Inadequate Documentation of Unilateral Do-No...

Mar 4, 2025  0

Molecular Phenotyping With Proteomics

Mar 11, 2025  0

Scabies Infestations—Reply

Feb 11, 2025  0